SNSmith & Nephew plc
1102.50GBp+0.87%Mkt Cap: 9.42B GBpP/E: 20.83Last update: 2026-05-13

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three seg…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)20.83
P/E (Forward)12.09
PEG1.21
P/B2.42
P/S1.54
EV/EBITDA9.15
EV/Revenue1.98
EPS (TTM)0.53
EPS (Forward)0.92
Cash Flow & Leverage
FCF Yield9.30%
FCF Margin14.22%
Operating CF1.28B GBp
CapEx (TTM)433.00M GBp
Net Debt/EBITDA2.07
Net Debt2.77B GBp
Technical
SMA 501193.43 (-7.6%)
SMA 2001277.37 (-13.7%)
Beta0.67
S&P 52W Chg24.23%
Avg Vol (30d)2.95M
Avg Vol (10d)3.60M
Technical Indicators
RSI (14)32.8
MACD-33.8055
MACD Signal-25.7574
MACD Hist.-8.0480
BB Upper1303.49 GBp
BB Middle1183.50 GBp
BB Lower1063.51 GBp
BB Width20.28%
ATR (14)28.47 GBp
Vol Ratio (20d)1.59x
52W Range
1051.4713% of range1441.50
52W High1441.50 GBp
52W Low1051.47 GBp
Profitability
Gross Margin68.01%
EBITDA Margin21.67%
Profit Margin10.14%
Oper. Margin13.99%
ROE11.82%
ROA5.98%
Revenue Growth7.40%
Earnings Growth70.40%
Balance Sheet
Debt/Equity0.63
Current Ratio2.57
Quick Ratio1.17
Book Value/Sh4.599 GBp
Cash/Share0.6550 GBp
Dividends
Fwd Div Rate0.2900 GBp
Trail. Div Rate0.3910 GBp
Div. Yield2.61%
5Y Avg Yield2.57%
Payout Ratio52.72%
Ex-Div DateMar 26, 2026
Pay Date
Splits
Last Split9:11
Split DateAug 7, 2000
Ownership
Shares Out.853.65M
Float839.97M
Insiders0.22%
Institutions71.08%
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)1428.44 GBp
Target Range1196.54 GBp1698.30 GBp
# Analysts17
Company
Market Cap9.42B GBp
Enterprise Value12.22B GBp
Revenue (TTM)6.16B GBp
Gross Profit4.19B GBp
Net Income (TTM)625.00M GBp
Revenue/Share7.110 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees17.0K
Last Price1102.50 GBp
CountryGB
SectorHealthcare
IndustryMedical Devices
ISINGB0009223206